# CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
Canonical URL: https://biopharmsignal.com/news/CRSP/crispr-therapeutics-provides-business-update-and-reports-first-quarter-2026-financial-results
Ticker: CRSP
Company: CRISPR Therapeutics
Source: CRISPR Therapeutics
Published: 2026-05-04 20:30 EST
Original Source URL: https://ir.crisprtx.com
## Summary

ZUG, Switzerland and BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026. “The first quarter reflected continued execution across CRISPR Therapeutics’ platform,” said Samarth Kulkarni, Ph.D.,

## Article Body
ZUG, Switzerland and BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026. “The first quarter reflected continued execution across CRISPR Therapeutics’ platform,” said Samarth Kulkarni, Ph.D.,
## Recent Company News
- 2026-05-28 12:00 EST — [CRISPR Therapeutics to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/CRSP/crispr-therapeutics-to-participate-in-upcoming-investor-conferences) — Source: CRISPR Therapeutics
- 2026-05-06 12:30 EST — [CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference](https://biopharmsignal.com/news/CRSP/crispr-therapeutics-to-present-at-the-bank-of-america-securities-2026-global-healthcare-conference) — Source: CRISPR Therapeutics
- 2026-05-04 20:30 EST — [CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/CRSP/crispr-therapeutics-provides-business-update-and-reports-first-quarter-2026-financial-results) — Source: CRISPR Therapeutics
- 2026-04-07 12:00 EST — [CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/CRSP/crispr-therapeutics-to-present-at-the-25th-annual-needham-virtual-healthcare-conference) — Source: CRISPR Therapeutics
- 2026-03-11 11:00 EST — [CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering](https://biopharmsignal.com/news/CRSP/crispr-therapeutics-prices-upsized-convertible-senior-notes-offering) — Source: CRISPR Therapeutics
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)